Thursday, June 26, 2014

FDA Warns GSK plant

Flulaval is the company’s older flu drug, which has been to some extent superceded by Relenza – but FDA inspectors noted “deviations from current good manufacturing practice (CGMP) requirements” in its production at GSK’s plant in Quebec. 
Continue to read here

No comments: